# FDA Inspection 1000724 - Reliant Holding, Ltd. - February 02, 2017

Source: https://www.keypedia.com/records/fda_inspections/reliant-holding-ltd/150e5012-ca03-494f-ba72-76de4497e84f
Source feed: FDA_Inspections

> FDA Inspection 1000724 for Reliant Holding, Ltd. on February 02, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1000724
- Company Name: Reliant Holding, Ltd.
- Inspection Date: 2017-02-02
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1290004 - 2025-10-29](https://www.keypedia.com/records/fda_inspections/reliant-holding-ltd/0cee8c48-cea7-4e14-970e-4d781240eb06)
- [FDA Inspection 1290004 - 2025-10-29](https://www.keypedia.com/records/fda_inspections/reliant-holding-ltd/0ea44df4-e42b-465d-a116-15a1409bc9e7)
- [FDA Inspection 968748 - 2016-03-24](https://www.keypedia.com/records/fda_inspections/reliant-holding-ltd/c65df90b-3b73-441c-b7f9-802ad00e3621)

Company: https://www.keypedia.com/companies/reliant-holding-ltd/14966b48-ea6c-415f-86f0-ac8d2585ef22

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
